Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 30 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §102 only | 2 (40%) |
| §112 only | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KORANG-BEHESHTI, YOSSEF | 1 | 73.4% | +11.0% |
| SPRATT, BEAU D | 1 | 78.9% | +25.2% |
| APPLEGATE, SARAH ARIMINTIA | 1 | 62.5% | +42.9% |
| ROBINSON, MICHAEL | 1 | 61.6% | +21.3% |
| REGLAS, GILLIAN CHELSEA | 1 | 27.5% | +55.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17461094 | USE OF ENDOTHELIAL PROGENITOR CELLS IN REJUVENATING THE MICROVASCULATURE, PREVENTING AGING AND TREATING AGE-RELATED DISEASES | REGLAS, GILLIAN CHELSEA | 87d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17754714 | RUBBER CONCRETE PRODUCT | ROBINSON, MICHAEL | 103d overdue |
| 17461094 | USE OF ENDOTHELIAL PROGENITOR CELLS IN REJUVENATING THE MICROVASCULATURE, PREVENTING AGING AND TREATING AGE-RELATED DISEASES | REGLAS, GILLIAN CHELSEA | 87d overdue |
| 18198898 | MULTI-VIEW SINGLE-FRAME PHASE DEMODULATION METHOD BASED ON STRUCTURED LIGHT FIELD AND RELATED COMPONENTS | SPRATT, BEAU D | 10d overdue |
| 18457947 | DATA ACTIVE SELECTION AND ANNOTATION METHOD AND APPARATUS FOR POINT CLOUD | KORANG-BEHESHTI, YOSSEF | 62d |
| 18118139 | COMPOSITE BINDER FOR SELF-EXTINGUISHING LITHIUM ION BATTERY AND LITHIUM ION BATTERY | APPLEGATE, SARAH ARIMINTIA | 71d |
| Art Unit | Apps |
|---|---|
| 2857 | 1 |
| 2143 | 1 |
| 1725 | 1 |
| 1744 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18457947 | DATA ACTIVE SELECTION AND ANNOTATION METHOD AND APPARATUS FOR POINT CLOUD | KORANG-BEHESHTI, YOSSEF | 2857 | §102 | Non-Final OA | 62d | Pending | Aug 29, 2023 |
| 18198898 | MULTI-VIEW SINGLE-FRAME PHASE DEMODULATION METHOD BASED ON STRUCTURED LIGHT FIELD AND RELATED COMPONENTS | SPRATT, BEAU D | 2143 | §103 | Non-Final OA | 10d overdue | Pending | May 18, 2023 |
| 18118139 | COMPOSITE BINDER FOR SELF-EXTINGUISHING LITHIUM ION BATTERY AND LITHIUM ION BATTERY | APPLEGATE, SARAH ARIMINTIA | 1725 | §103 | Final Rejection | 71d | Pending | Mar 07, 2023 |
| 17754714 | RUBBER CONCRETE PRODUCT | ROBINSON, MICHAEL | 1744 | §112 | Non-Final OA | 103d overdue | Pending | Apr 08, 2022 |
| 17461094 | USE OF ENDOTHELIAL PROGENITOR CELLS IN REJUVENATING THE MICROVASCULATURE, PREVENTING AGING AND TREATING AGE-RELATED DISEASES | REGLAS, GILLIAN CHELSEA | 1632 | §102 | Non-Final OA | 87d overdue | Pending | Aug 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial